| Name | (1aS,1bS,2S,5aR,6S,6aS)-2-(β-D-Glucopyranosyloxy)-1a-(hydroxymeth yl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-6 -yl (2E)-3-(3-hydroxy-4-methoxyphenyl)acrylate |
|---|---|
| Synonyms |
(1aS,1bS,2S,5aR,6S,6aS)-2-(β-D-Glucopyranosyloxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-6-yl (2E)-3-(3-hydroxy-4-methoxyphenyl)acrylate
β-D-Glucopyranoside, (1aS,1bS,2S,5,6S,6aS)-1a,1b,2,5a,6,6a-hexahydro-6-[[(2E)-3-(3-hydroxy-4-methoxyphenyl)-1-oxo-2-propen-1-yl]oxy]-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl (1aS,1bS,2S,5,6S,6aS)-2-(β-D-Glucopyranosyloxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-6-yl(2E)-3-(3-hydroxy-4-methoxyphenyl)acrylate a-D-Glucopyranoside,(1aS,1bS,2S,5,6S,6aS)- 1a,1b,2,5a,6,6a-hexahydro-6-[[(2E)-3-(3- hydroxy-4-methoxyphenyl)-1-oxo-2-propenyl]- oxy]-1a-(hydroxymethyl)oxireno[4,5]cyclopenta- [1,2-c]pyran-2-yl Minecoside >= (LC/MS-ELSD) |
| Description | Minecoside is a CXCR4/STAT3 inhibitor with anticancer and anti-inflammatory activity. Minecoside decreases CXCR4 expression and suppresses STAT3 activation, thus to inhibit CXCL 12-induced invasion. Minecoside potently inhibits cancer metastasis and promotes apoptotic progression[1][2]. |
|---|---|
| Related Catalog | |
| Target |
CXCR4; STAT3 |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 815.9±65.0 °C at 760 mmHg |
| Melting Point | 142℃ |
| Molecular Formula | C25H30O13 |
| Molecular Weight | 538.50 |
| Flash Point | 275.7±27.8 °C |
| Exact Mass | 538.168640 |
| PSA | 197.13000 |
| LogP | -2.66 |
| Vapour Pressure | 0.0±3.1 mmHg at 25°C |
| Index of Refraction | 1.678 |
| Storage condition | ?20°C |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H319 |
| Precautionary Statements | P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Phrases | 36 |
| Safety Phrases | 26 |
| RIDADR | NONH for all modes of transport |